> top > docs > PubMed:15816521 > annotations

PubMed:15816521 JSONTXT

Annnotations TAB JSON ListView MergeView

DisGeNET

Id Subject Object Predicate Lexical cue
T0 1208-1220 gene:4792 denotes IkappaBalpha
T1 1250-1256 disease:C0006826 denotes cancer
T2 1208-1220 gene:4792 denotes IkappaBalpha
T3 1250-1256 disease:C1306459 denotes cancer
R1 T0 T1 associated_with IkappaBalpha,cancer
R2 T2 T3 associated_with IkappaBalpha,cancer

PubMed_Structured_Abstracts

Id Subject Object Predicate Lexical cue
T1 135-467 BACKGROUND denotes Nuclear factor kappaB (NFkappaB) is an inducible and ubiquitously expressed transcription factor which is involved in cell survival, differentiation and growth and, thus, has also been implicated in tumor formation and development. Research on the effect of NFkappaB in inhibiting cancer cell growth, however, remains controversial.
T2 491-672 METHODS denotes We investigated the effects of overexpressed IkappaBalpha on the proliferation of the human lung cancer cell line H460 in vitro and in vivo using IkappaBalpha-expressing adenovirus.
T3 682-1175 RESULTS denotes The results suggested that the infection of AdIkappaBalpha blocked NFkappaB activity in H460 cells and significantly inhibited cell proliferation by inducing apoptosis. An in vivo study showed the tumor incidence to be significantly lower in mice implanted with H460 cells infected with AdIkappaBa. For established H460 tumor, the intratumoral injection of AdIkappaBalpha also inhibited the tumor growth due to both a blockade of the NFkappaB activity and an inhibition of the VEGF expression.
T4 1188-1276 CONCLUSIONS denotes Adenovirus-mediated IkappaBalpha gene transfer is a promising cancer treatment strategy.